References
Almaaytah A, Abualhaijaa A, & Alqudah O (2019). The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria. Infect Drug Resist 12: 1371-1380.
Almaaytah A, Farajallah A, Abualhaijaa A, & Al-Balas Q (2018). A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria. Molecules 23.
Almaaytah A, Tarazi S, Abu-Alhaijaa A, Altall Y, Alshar’i N, Bodoor K, et al. (2014). Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1. Pharmaceuticals (Basel) 7:502-516.
Almaaytah A, Zhou M, Wang L, Chen T, Walker B, & Shaw C (2012). Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Peptides 35: 291-299.
Ardal C, Balasegaram M, Laxminarayan R, McAdams D, Outterson K, Rex JH, et al. (2020). Antibiotic development - economic, regulatory and societal challenges. Nat Rev Microbiol 18: 267-274.
Bell G, & MacLean C (2018). The Search for ’Evolution-Proof’ Antibiotics. Trends Microbiol 26: 471-483.
Bjorn C, Noppa L, Naslund Salomonsson E, Johansson AL, Nilsson E, Mahlapuu M, et al. (2015). Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds. Int J Antimicrob Agents 45: 519-524.
Brogden KA (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, & White TC (2012). Hidden killers: human fungal infections. Sci Transl Med 4:165rv113.
Brown GD, Denning DW, & Levitz SM (2012). Tackling human fungal infections. Science 336: 647.
Cao J, Wu P, Cheng Q, He C, Chen Y, & Zhou J (2021). Ultrafast Fabrication of Self-Healing and Injectable Carboxymethyl Chitosan Hydrogel Dressing for Wound Healing. ACS applied materials & interfaces 13: 24095-24105.
Cebrian R, Xu C, Xia Y, Wu W, & Kuipers OP (2021). The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo. Int J Antimicrob Agents 58: 106434.
Curren EJ, Lutgring JD, Kabbani S, Diekema DJ, Gitterman S, Lautenbach E, et al. (2022). Advancing Diagnostic Stewardship for Healthcare-Associated Infections, Antibiotic Resistance, and Sepsis. Clin Infect Dis 74: 723-728.
Echaiz JF, Burnham CA, & Bailey TC (2013). A case of Apophysomyces trapeziformis necrotizing soft tissue infection. Int J Infect Dis 17: e1240-1242.
Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, McCraw SL, et al. (2012). Emerging fungal threats to animal, plant and ecosystem health. Nature 484: 186-194.
Gao W, & Zhang L (2021). Nanomaterials arising amid antibiotic resistance. Nat Rev Microbiol 19: 5-6.
Ghosh C, Sarkar P, Issa R, & Haldar J (2019). Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance. Trends Microbiol 27: 323-338.
Hancock REW, Alford MA, & Haney EF (2021). Antibiofilm activity of host defence peptides: complexity provides opportunities. Nat Rev Microbiol 19: 786-797.
Hofer U (2019). The cost of antimicrobial resistance. Nat Rev Microbiol 17: 3.
Hofer U (2022). Rise in global antibiotic use. Nat Rev Microbiol 20: 63.
Larsson DGJ, & Flach CF (2021). Antibiotic resistance in the environment. Nat Rev Microbiol.
Lei R, Hou J, Chen Q, Yuan W, Cheng B, Sun Y, et al. (2018). Self-Assembling Myristoylated Human alpha-Defensin 5 as a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection. Acs Nano 12: 5284-5296.
Liang YP, He JH, & Guo BL (2021). Functional Hydrogels as Wound Dressing to Enhance Wound Healing. Acs Nano 15: 12687-12722.
Liang YQ, Li ZL, Huang Y, Yu R, & Guo BL (2021). Dual-Dynamic-Bond Cross-Linked Antibacterial Adhesive Hydrogel Sealants with On-Demand Removability for Post-Wound-Closure and Infected Wound Healing. Acs Nano 15: 7078-7093.
Makabenta JMV, Nabawy A, Li CH, Schmidt-Malan S, Patel R, & Rotello VM (2021). Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol 19: 23-36.
Mwangi J, Yin Y, Wang G, Yang M, Li Y, Zhang Z, et al. (2019). The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection. Proceedings of the National Academy of Sciences of the United States of America.
Nibbering PH, Goblyos A, Adriaans AE, Cordfunke RA, Ravensbergen B, Rietveld MH, et al. (2019). Eradication of meticillin-resistant Staphylococcus aureus from human skin by the novel LL-37-derived peptide P10 in four pharmaceutical ointments. Int J Antimicrob Agents 54: 610-618.
Pambos OJ, & Kapanidis AN (2019). Tracking antibiotic mechanisms. Nat Rev Microbiol 17: 201.
Pfaller MA, & Diekema DJ (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163.
Song M, Liu Y, Huang X, Ding S, Wang Y, Shen J, et al. (2020). A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens. Nat Microbiol 5: 1040-1050.
van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, et al. (2019). Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles. Int J Antimicrob Agents 54:159-166.